NASDAQ: DCGODocgo Inc Stock
$0.36-0.01 (-2.7%)
Updated Sep 18, 2026
DCGO Price
$0.36
Fair Value Price
N/A
Market Cap
$35.52M
52 Week Low
$0.35
52 Week High
$1.65
P/E
-0.19x
P/B
0.3x
P/S
0.17x
PEG
N/A
Dividend Yield
N/A
Revenue
$294.72M
Earnings
-$192.42M
Gross Margin
30.1%
Operating Margin
-59.23%
Profit Margin
-65.3%
Debt to Equity
0.77
Operating Cash Flow
-$23M
Beta
1.25
Next Earnings
Nov 9, 2026
Ex-Dividend
N/A
Next Dividend
N/A
DCGO Overview
DocGo, Inc. provides medical transportation services to health care providers in the U.S. and UK. Offerfings include ambulance services and wheelchair transportation services. It also offers mobile health services at homes and offices, COVID-19 testing, and on-site healthcare support at sporting events and concerts. DocGo was incorporated in 2015 and is headquartered in New York, NY.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine DCGO's potential to beat the market
- DCGO doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Care Facility
Industry Rating
A
DCGO
RankedUnranked of 43
RankedUnranked of 43
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $25.93 | A | |
| $261.99 | A | |
| $5.10 | B |
Be the first to know about important DCGO news, forecast changes, insider trades & much more!
DCGO News
Overview
Due Diligence Score
–
Industry Average (32)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how DCGO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
DCGO is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
DCGO is good value based on its book value relative to its share price (0.3x), compared to the US Medical Care Facilities industry average (5.55x)
P/B vs Industry Valuation
DCGO is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more DCGO due diligence checks available for Premium users.
Valuation
DCGO fair value
Fair Value of DCGO stock based on Discounted Cash Flow (DCF)
Price
$0.36
Fair Value
$1.72
Undervalued by
79.07%
DCGO is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
DCGO price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.19x
Industry
14.89x
Market
44.48x
DCGO price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.3x
Industry
5.55x
DCGO is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
DCGO's financial health
Profit margin
Revenue
$73.4M
Net Income
-$15.8M
Profit Margin
-21.5%
DCGO's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
DCGO's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$186.8M
Liabilities
$91.0M
Debt to equity
0.77
DCGO's short-term assets ($119.80M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
DCGO's short-term assets ($119.80M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
DCGO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$9.2M
Investing
-$3.9M
Financing
-$1.7M
DCGO's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
DCGO vs Medical Care Facility Stocks
Docgo Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.